SG10201508420VA - Improved harvest operations for recombinant proteins - Google Patents

Improved harvest operations for recombinant proteins

Info

Publication number
SG10201508420VA
SG10201508420VA SG10201508420VA SG10201508420VA SG10201508420VA SG 10201508420V A SG10201508420V A SG 10201508420VA SG 10201508420V A SG10201508420V A SG 10201508420VA SG 10201508420V A SG10201508420V A SG 10201508420VA SG 10201508420V A SG10201508420V A SG 10201508420VA
Authority
SG
Singapore
Prior art keywords
recombinant proteins
harvest operations
improved harvest
improved
operations
Prior art date
Application number
SG10201508420VA
Other languages
English (en)
Inventor
Michael W Laird
John Richard St
Jane V Gunson
Kim Kaleas
Deepa Nadarajah
Rachel Adams
Bradley R Snedecor
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SG10201508420VA publication Critical patent/SG10201508420VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/40Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/42Means for regulation, monitoring, measurement or control, e.g. flow regulation of agitation speed
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Sustainable Development (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10201508420VA 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins SG10201508420VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261616297P 2012-03-27 2012-03-27

Publications (1)

Publication Number Publication Date
SG10201508420VA true SG10201508420VA (en) 2015-11-27

Family

ID=48040433

Family Applications (4)

Application Number Title Priority Date Filing Date
SG10201508420VA SG10201508420VA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG10201912877SA SG10201912877SA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG11201406112TA SG11201406112TA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG10202007206WA SG10202007206WA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins

Family Applications After (3)

Application Number Title Priority Date Filing Date
SG10201912877SA SG10201912877SA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG11201406112TA SG11201406112TA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG10202007206WA SG10202007206WA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins

Country Status (21)

Country Link
US (8) US20140080180A1 (ja)
EP (1) EP2831261B1 (ja)
JP (4) JP6225162B2 (ja)
KR (2) KR20200037425A (ja)
CN (2) CN104350156B (ja)
AR (2) AR090340A1 (ja)
AU (3) AU2013240280A1 (ja)
BR (1) BR112014023176B1 (ja)
CA (2) CA3086730A1 (ja)
ES (1) ES2654424T3 (ja)
HK (1) HK1207120A1 (ja)
HR (1) HRP20171966T1 (ja)
IL (1) IL234377B (ja)
MX (3) MX365947B (ja)
MY (1) MY171729A (ja)
PL (1) PL2831261T3 (ja)
RU (2) RU2636353C2 (ja)
SG (4) SG10201508420VA (ja)
SI (1) SI2831261T1 (ja)
WO (1) WO2013148249A1 (ja)
ZA (1) ZA201406434B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201892820A1 (ru) 2016-06-10 2019-10-31 Способ стабилизации белков
TWI763732B (zh) 2016-11-07 2022-05-11 美商西雅圖遺傳學公司 工程化半胱胺酸帽之分佈
JP2021519298A (ja) * 2018-03-27 2021-08-10 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company 紫外線シグナルを使用した力価のリアルタイムモニタリング
CN109725088B (zh) * 2019-03-16 2021-05-18 丁立平 一种测定豆芽中2-萘甲酸及其衍生物的气相色谱-质谱联用法
CN110305903B (zh) * 2019-07-31 2021-10-01 江苏璟泽生物医药有限公司 重组人促卵泡激素及其制备方法
CN113155776A (zh) * 2021-04-29 2021-07-23 华东交通大学 一种柑桔最佳采收期预测方法

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2036891B (en) 1978-12-05 1983-05-05 Windsor Smith C Change speed gear
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5672347A (en) 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
EP0247091B1 (en) 1985-11-01 1993-09-29 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
WO1989012463A1 (en) 1988-06-21 1989-12-28 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
EP0602126B1 (en) 1991-08-14 2003-03-05 Genentech, Inc. Immunoglobulin variants for specific fc epsilon receptors
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US5288931A (en) 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
ATE149570T1 (de) 1992-08-17 1997-03-15 Genentech Inc Bispezifische immunoadhesine
WO1994004188A1 (en) 1992-08-21 1994-03-03 Genentech, Inc. Method for treating an lfa-1-mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5714338A (en) 1993-12-10 1998-02-03 Genentech, Inc. Methods for diagnosis of allergy
MX9602818A (es) 1994-01-18 1997-06-28 Genentech Inc Un metodo de tratamiento de infeccion parasitaria usando antagonistas ige.
US5707622A (en) 1994-03-03 1998-01-13 Genentech, Inc. Methods for treating ulcerative colitis
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
EP0831880A4 (en) 1995-06-07 2004-12-01 Imclone Systems Inc ANTIBODIES AND FRAGMENTS OF ANTIBODIES INHIBITING TUMOR GROWTH
ES2183131T3 (es) 1996-01-23 2003-03-16 Genentech Inc Anticuerpos anti-cd18 utilizados contra el ictus cerebral.
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
CA2272842C (en) 1996-11-27 2012-05-15 Genentech, Inc. Humanized anti-cd11a antibodies
ES2273415T3 (es) 1997-04-07 2007-05-01 Genentech, Inc. Anticuerpos anti-vegf.
JP2001511653A (ja) 1997-05-15 2001-08-14 ジェネンテク,インコーポレイテッド Apo−2レセプター
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
DE60039448D1 (de) 1999-10-29 2008-08-21 Genentech Inc Gegen das prostata-stammzellantigen (psca) gerichtete antikörper und deren verwendung
US6946271B2 (en) * 2000-09-20 2005-09-20 Degussa Ag Nucleotide sequences which code for the menE gene
US6979556B2 (en) 2000-12-14 2005-12-27 Genentech, Inc. Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
TWI335821B (en) 2002-12-16 2011-01-11 Genentech Inc Immunoglobulin variants and uses thereof
CA2520052C (en) * 2003-03-26 2011-07-19 Meiji Dairies Corporation Method for stabilizing 1,4-dihydroxy-2-napthoic acid
ATE353969T1 (de) * 2003-08-13 2007-03-15 Sandoz Ag Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide
CN1914330B (zh) * 2004-02-04 2012-10-24 默沙东公司 通过大肠杆菌发酵大规模生产质粒dna的方法
US7361764B2 (en) * 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
CN101115832A (zh) * 2004-11-26 2008-01-30 协和发酵工业株式会社 工业上有用的微生物
WO2007130655A2 (en) * 2006-05-05 2007-11-15 Gangagen, Inc. Phage derived antimicrobial activities
JP5305615B2 (ja) * 2006-06-05 2013-10-02 株式会社Adeka メナキノンの新規生合成経路に関与するタンパク質の遺伝子群を利用したメナキノンの製造方法
US20080125580A1 (en) * 2006-07-14 2008-05-29 Genentech, Inc. Refolding of Recombinant Proteins
KR20190140090A (ko) * 2007-07-09 2019-12-18 제넨테크, 인크. 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지
CN101665798B (zh) * 2008-09-06 2012-11-21 浙江我武生物科技股份有限公司 一种制备重组人血清白蛋白与干扰素α融合蛋白的方法
CN101503470A (zh) * 2008-09-27 2009-08-12 上海交通大学 rhDSL重组蛋白及其制备方法
JP2010088387A (ja) * 2008-10-10 2010-04-22 Waseda Univ 放線菌内で目的タンパク質を誘導発現可能なプロモーター

Also Published As

Publication number Publication date
AU2017202484A1 (en) 2017-05-04
MY171729A (en) 2019-10-25
US20150225760A1 (en) 2015-08-13
CN104350156A (zh) 2015-02-11
SG10202007206WA (en) 2020-08-28
JP2019141049A (ja) 2019-08-29
EP2831261B1 (en) 2017-10-18
US20200199639A1 (en) 2020-06-25
AU2019226192A1 (en) 2019-09-26
CA3086730A1 (en) 2013-10-03
HK1207120A1 (en) 2016-01-22
US20180291411A1 (en) 2018-10-11
US20140080180A1 (en) 2014-03-20
SI2831261T1 (en) 2018-01-31
AR090340A1 (es) 2014-11-05
KR20140148392A (ko) 2014-12-31
PL2831261T3 (pl) 2018-04-30
JP6225162B2 (ja) 2017-11-01
MX2014011558A (es) 2014-11-14
MX2018007677A (es) 2020-11-12
JP2020202849A (ja) 2020-12-24
CA2866753A1 (en) 2013-10-03
MX365947B (es) 2019-06-19
CN109880867A (zh) 2019-06-14
RU2017139267A (ru) 2019-02-12
SG10201912877SA (en) 2020-02-27
US9765379B2 (en) 2017-09-19
CN104350156B (zh) 2019-04-02
AU2013240280A1 (en) 2014-10-16
HRP20171966T1 (hr) 2018-02-09
BR112014023176B1 (pt) 2021-09-28
US20210171997A1 (en) 2021-06-10
MX2019007032A (es) 2019-08-16
RU2636353C2 (ru) 2017-11-22
US20160130624A1 (en) 2016-05-12
EP2831261A1 (en) 2015-02-04
AR116615A2 (es) 2021-05-26
US20240158825A1 (en) 2024-05-16
ZA201406434B (en) 2017-08-30
AU2017202484B2 (en) 2019-06-13
SG11201406112TA (en) 2014-10-30
CA2866753C (en) 2020-09-22
JP2018046825A (ja) 2018-03-29
KR102096678B1 (ko) 2020-04-02
ES2654424T3 (es) 2018-02-13
JP2015512259A (ja) 2015-04-27
RU2014137554A (ru) 2016-05-20
US20230069966A1 (en) 2023-03-09
IL234377B (en) 2021-01-31
BR112014023176A2 (pt) 2017-06-20
WO2013148249A1 (en) 2013-10-03
KR20200037425A (ko) 2020-04-08

Similar Documents

Publication Publication Date Title
HRP20190454T1 (hr) Rekombinantni faktor viii proteini
EP2929045A4 (en) PROTEIN EXPRESSION REINFORCING POLYPEPTIDES
SG11201400432VA (en) Polypeptide vaccine
IL235041A0 (en) Recombinant bacterial host cell for protein expression
HK1207120A1 (en) Improved harvest operations for recombinant proteins
HK1205524A1 (en) Engineered conformationally-stabilized proteins
HK1207259A1 (en) Novel protein material
HK1204948A1 (en) Radiation-sterilization-resistant protein composition
SG10201507721SA (en) CHO-GMT Recombinant Protein Expression
GB201220899D0 (en) CD44v6-derived pegylated peptides
GB201304973D0 (en) Recombinant protein
GB201223114D0 (en) Novel peptide
HK1207258A1 (en) Novel protein material
HK1201752A1 (en) Alternaria peptides
HK1211952A1 (en) Recombinant protein
GB201210286D0 (en) Recombinant polypeptide
GB201215901D0 (en) Protein modification
GB201213672D0 (en) Protein
GB201112985D0 (en) Polypeptide
GB201112849D0 (en) Polypeptide
GB201106130D0 (en) Polypeptide